SIGA Technologies, Inc. (SIGA) |
|
10.28 -0.16 (-1.53%)
|
09-24 15:22 |
|
Open: |
10.35 |
Pre. Close: |
10.44 |
|
High:
|
10.5 |
Low:
|
9.95 |
|
Volume:
|
2,123,732 |
Market Cap:
|
751(M) |
|
|
|
|
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.57 - 10.67 |
10.67 - 10.73 |
|
Low:
|
9.74 - 9.87 |
9.87 - 9.95 |
|
Close:
|
10.13 - 10.34 |
10.34 - 10.47 |
|
Technical analysis |
as of: 2022-09-23 4:27:28 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 21.86  One year: 28.19 |
| Support: |
Support1: 9.94 Support2: 8.27 |
| Resistance: |
Resistance1: 18.71 Resistance2: 24.13 |
| Pivot: |
12.53 |
| Moving Average: |
MA(5): 10.84 MA(20): 13.28
MA(100): 14.05  MA(250): 9.9 |
| MACD: |
MACD(12,26): -2.1 Signal(9): -1.8 |
| Stochastic oscillator: |
%K(14,3): 3.4 %D(3): 2.3 |
| RSI: |
RSI(14): 24.1 |
| 52-week: |
High: 26.98 Low: 5.84 |
| Average Vol(K): |
3-Month: 10,100 (K) 10-Days: 2,393 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SIGA ] has closed above bottom band by 8.2%. Bollinger Bands are 22.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 23 Sep 2022
With monkeypox evolving, FDA says overuse of Siga's Tpoxx could render it ineffective - FiercePharma
Fri, 23 Sep 2022
Institutional investors in SIGA Technologies, Inc. (NASDAQ:SIGA) see US$167m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St
Wed, 21 Sep 2022
Should You Sell SIGA Technologies, Inc. (SIGA) Stock Wednesday Morning? - InvestorsObserver
Sun, 18 Sep 2022
SIGA Sport Integrity Week: Day 4 summary: standards fundamental for the future of sport - AS USA
Thu, 15 Sep 2022
Better Monkeypox Stock: SIGA Technologies vs. Quest Diagnostics - The Motley Fool
Fri, 09 Sep 2022
What is the Market's View on SIGA Technologies, Inc. (SIGA) Stock's Price and Volume Trends Friday? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
73 (M) |
| Shares Float |
39 (M) |
|
% Held by Insiders
|
44 (%) |
|
% Held by Institutions
|
44.2 (%) |
|
Shares Short
|
5,630 (K) |
|
Shares Short P.Month
|
4,070 (K) |
Stock Financials |
|
EPS
|
0.91 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.9 |
|
Profit Margin (%)
|
48.6 |
|
Operating Margin (%)
|
62.8 |
|
Return on Assets (ttm)
|
39.4 |
|
Return on Equity (ttm)
|
55.9 |
|
Qtrly Rev. Growth
|
92.5 |
|
Gross Profit (p.s.)
|
1.45 |
|
Sales Per Share
|
2.01 |
|
EBITDA (p.s.)
|
1.27 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
72 (M) |
|
Levered Free Cash Flow
|
58 (M) |
Stock Valuations |
|
PE Ratio
|
11.29 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
5.38 |
|
Price to Sales
|
5.09 |
|
Price to Cash Flow
|
10.39 |
Stock Dividends |
|
Dividend
|
0.44 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
4.3% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
